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Abstract 
BACKGROUND: Preeclampsia can be divided into early (EOPE) and late (LOPE) onset preeclampsia. 
Preeclampsia is related to the failure of placentation. Accumulation of hypoxia-inducible factors (HIF)-1α is 
commonly an acute and beneficial respond to hypoxia, while chronically elevated is associated with preeclampsia. 
AIM: This study aims to evaluate the serum levels of HIF-1α in preeclampsia and normal pregnancy, and to 
compare the difference between early-onset and late-onset preeclampsia. 
METHODS: A cross-sectional comparative study was conducted among a total of 69 pregnant women at ≥ 20 
weeks of gestation, were recruited at obstetrics and gynaecology department at Dr M. Djamil Padang Hospital, 
network hospitals, health centres. They were divided into three groups early-onset preeclampsia, late-onset 
preeclampsia, and normal pregnancy. Preeclampsia was diagnosed using International Guidelines. Data were 
analysed by SPSS 24 program; data are presented as median and range or as mean ± standard deviation. One-
way ANOVA test was used to determine the relationship between HIF-1α levels with the onset of preeclampsia. 
RESULTS: The results showed that the mean maternal serum HIF-1α levels in early-onset preeclampsia (EOPE), 
late-onset preeclampsia (LOPE), and normal pregnancy were 1366.96 ± 733.40 pg/ml, 916.87 ± 466.06 pg/ml, 
and 716.77 ± 541.08 pg/ml. Serum HIF-1α levels were higher in early-onset preeclampsia (EOPE), and late-onset 
preeclampsia (LOPE) compared to normal pregnancy. Among preeclampsia patients, serum HIF-1α was higher in 
EOPE than LOPE women. Statistical analysis revealed a significant difference in mean maternal serum HIF-1α 
between early-onset preeclampsia, late-onset preeclampsia, and normal pregnancy (p < 0.05). 
CONCLUSION: This study concluded that there is a significantly different level of HIF-1α between in early-onset 
preeclampsia, late-onset preeclampsia and normal pregnancy. Early-onset preeclampsia is the highest levels of 
serum HIF-1α. 
 
 
 
 
Introduction 
 
Preeclampsia is a multisystem disorder that 
occurs in about 2-10% of all pregnancies and most 
often causes maternal and fetal morbidity and 
mortality [1], [2]. The World Health Organization 
(WHO) reports 16% of maternal mortality caused by 
preeclampsia in developing countries [3]. 
Preeclampsia can be divided into sub-classifications: 
early-onset preeclampsia (EOPE) and late-onset 
preeclampsia (LOPE). The risk of maternal and fetal 
mortality in early-onset preeclampsia (EOPE) is 
significantly greater than that of late-onset 
preeclampsia (LOPE), this is due to the large majority 
of problems with severe placental perfusion and 
prematurity [4]. Most newborns from EOPE 
pregnancies experience premature and fetal growth 
restriction (FGR) [5], [6]. 
Based on the research which is placenta 
molecular basically, EOPE has oxygen level more 
than LOPE. Van der Merwe et al., (2010) report that 
placenta of EOPE is smaller has more infarct, and 
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unexact maturation, meanwhile placenta of LOPE has 
enhancement of decidual arteriopathy and placental 
solution [7]. 
EOPE occurs in 5-20% of all cases of 
preeclampsia associated with impaired fetal growth, 
pathological fetus, impaired uterine blood circulation, 
small placental size, preterm birth, and neonatal 
mortality whereas LOPE is around 75-80% of the total 
cases of preeclampsia associated with maternal 
mobility (such as metabolic syndrome, impaired 
glucose tolerance, obesity, dyslipidemia, chronic 
hypertension), with normal fetal weight and normal 
placental volume [7]. Although the aetiology of 
preeclampsia is unclear, abnormalities in the placenta 
are undoubtedly the pathogenesis of preeclampsia. 
The presence of abnormal placentations, including 
incomplete trophoblast spiral arteries invasion, plays 
an important role as the pathogenesis and 
pathophysiology of preeclampsia [1], [8].
 
Preeclampsia is related with failure of 
placentation, which is begin by the failure of arterial 
spiralis remodelling to the place of implantation. The 
pathological change of preeclampsia signed bg anti-
angiogenesis, hypoxia, endosteal dysfunction, and 
interference of immunology's response, which cause 
disturbance of morphology and histopathology of 
many organs such as heart, lung, kidney, heart, brain 
and placenta [9].  
Accumulation of hypoxia-inducible factor 1 α 
(HIF-1α) is commonly an acute and beneficial respond 
to hypoxia, while chronically elevated HIF-1α is 
associated with multiple disease conditions, including 
preeclampsia [10]. 
The initial phase of placentation happened 
under the relative hypoxia condition. HIF-1α as the 
marker of the cellular oxygen deprivation, expressed 
by its high level in the trophoblast. Persistent hypoxia 
or the failure to decrease the expression of 
transforming growth factor β3 (TGF-β3) after the ninth 
month of the pregnancy cause failure of trophoblast to 
differentiate from proliferative phenotype become 
invasive. The expression of HIF-1α is regulated not 
only by hypoxia but also by inflammation stimulation 
(for example, thrombin, peptide cytokine, like tumour 
necrosis factor (TNF), and reactive oxygen species 
(ROS), especially mediated by nuclear factor κB (NF-
κB), as the promotor of HIF-1α contains binding site of 
NF-κB [9]. 
The availability of oxygen greatly influences 
placental function at all stages of pregnancy, and 
hypoxia-inducible factors (HIF) are the main mediator 
of placental adaptation [11]. During hypoxia, HIFs are 
stabilised and act as transcription factors [12]. During 
low oxygen conditions, HIF-1α is expressed high and 
helps placental development early in pregnancy. 
Excessive expression of HIF-1α has been observed in 
many inflammatory disorders, including cancer and 
preeclampsia [13]. 
The role of HIF-1α in the pathogenesis of 
preeclampsia is evidenced by Cannigia et al., (2000) 
which shows that HIF-1α is expressed more by the 
placenta with a low oxygen condition at initial 
gestation, then decreases at week 9 gestational age 
when oxygen levels begin to increase [14]. Likewise, 
with the research of Rajakumar et al., (2000) which 
states that HIF-1α plays an important role in the 
development and function of the placenta [15], [16]. 
Bobek et al. (2015) also researched mice and found 
that HIF-1α induced by cytokine imbalance, plays a 
role in the pathogenesis of preeclampsia [17]. Another 
study by Akhilesh et al. (2013) proves that HIF-1α 
levels in preeclampsia women are higher than 
controls [18]. 
Research on the relationship of HIF-1α levels 
in preeclampsia, especially in EOPE, where there is 
still not much research done, and the results are still 
controversial. The goals of this study were to 
evaluated the serum levels of HIF-1α in preeclampsia 
and normal pregnancy and to compare the difference 
between early-onset and late-onset preeclampsia. 
 
 
Material and Method 
 
Subjects  
The study was conducted at Dr M. Djamil 
Hospital Padang, network hospitals and health 
centres. The study used a cross-sectional 
comparative study design by comparing the three 
study groups, namely early-onset preeclampsia, late-
onset preeclampsia, and normal pregnancy to 
evaluated the serum levels of HIF-1α in preeclampsia 
and normal pregnancy and to compare the difference 
between early-onset and late-onset preeclampsia. 
Preeclampsia is defined as hypertension with 
minimum criteria for systolic blood pressure ≥ 140 
mmHg and/or diastolic blood pressure ≥ 90 mmHg 
after 20 weeks' gestation, and one or more proteinuria 
≥ 300 mg / 24 hours or urine / creatinine protein ratio 
≥ 30 mg / dl (1 + urine dipstick), renal insufficiency, 
hematological abnormalities, liver disorders, cerebral 
disorders, pulmonary edema. The number of samples 
was 69 samples that met the inclusion criteria (single 
pregnancy women, gestational age > 20 weeks, there 
were no severe medical abnormalities, no 
chorioamnionitis and no pregnancy with major 
congenital abnormalities), and exclusion criteria 
damage to blood samples during the research 
process and patients drop out during the research 
process). The study was conducted at Dr M. Djamil 
Padang Hospital, network hospitals and health 
centres. In patients who come in the third trimester, 
into the late-onset sample because sampling is done 
when the patient first arrives. 
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Samples  
Patients who meet the inclusion and exclusion 
criteria will be interviewed to obtain characteristic data 
including name, age, identity number, address, 
contact number, history of pregnancy, the first day of 
the last day or ultrasound examination to assess 
gestational age. The size of the samples is calculated 
according to the simple formula to estimate the 
proportion of a population. The sampling formula used 
in unpaired numerical comparative research [19]. The 
sampling technique is done by the consecutive 
method, i.e. the samples are taken sequentially. By 
the inclusion criteria and exclusion until the required 
number of samples is fulfilled. After the patient signed 
a letter of informed consent, venous blood specimens 
were collected in the median cubital vein by folding 
the elbow by 10 ml. Next blood is sent to the 
laboratory for examination HIF-1α levels. Examination 
of HIF-1α levels using reagents from the Human 
Hypoxia Inducible Factor-1α ELISA Kit (Catalog No: 
E-EL-H1277, R & D System, USA). How to measure 
BMI before pregnancy is by asking the patient the 
weight and height of the patient before the detection 
of pregnancy. In this study, patients were not followed 
up until birth. This baby weight data is obtained from 
secondary data available. 
 
Examination of HIF-1α Levels (Work 
 protocol based on the Human HIF-1α 
 ELISA Kit) 
Prepare all reagents and samples at the 
examination room temperature. Add 100 ul, blank and 
sample into each well. Add 100 ul Biotinylated 
Detection Abworking solution into each well, cover 
with plate sealer. One-hour incubation at 37°C. 
Dispose of all fluids in the well. Wash well by adding 
350 ul of wash buffer solution. Repeat three items of 
washing. Add 100 ul Avidin-Horseradish Peroxidase 
(HRP) Conjugate working solution to all wells. Cover 
with plate sealer. Incubate for 30 minutes at 37°C. 
Repeat the washing process as in step 5 five times. 
Add 90 ul of the Substrate Reagent solution to each 
well. Cover with a new plate sealer. Incubation for 15 
minutes at 37°C. Avoid bright light. Add 50 ul Stop 
Solution to each well. Read the results of the 
inspection with the ELISA reader at a wavelength of 
450 nm. Optical density (OD) values and 
concentration values of samples were examined. 
 
Statistical Analysis  
Data were analysed by SPSS 24 program; 
data are presented as median and range or as mean 
± standard deviation. One-way ANOVA test was used 
to evaluate the serum levels of HIF-1α in 
preeclampsia and normal pregnancy, and to compare 
the difference between early-onset and late-onset 
preeclampsia, if a p-value of < 0.05 was obtained, a 
significant association was found HIF-1α levels with 
the onset of preeclampsia. 
 
 
Results 
The study was conducted on 69 patients 
consisting of 23 early-onset preeclampsia, 23 late-
onset preeclampsia and 23 normal pregnancies. 
Sample characteristic of 69 patients, based on age, 
gestational age, parity, systole and diastole blood 
pressure, body mass index (BMI), and birth weight 
was shown in Table 1. 
Table 1: Clinical characteristics of the study population 
Characteristic EOPE (n = 23) LOPE (n = 23) Normal (n = 23) 
Age of pregnant women (year) 32.35 ± 7.33 32.96 ± 6.8 29.30 ± 2.18 
Gestational age (week) 29.04 ± 3.37 36.91 ± 2.04 38.22 ± 0.67 
Parity (%)    
- Nullipara 34.8 39.1 4.3 
- Multipara 65.2 60.9 95.7 
Systolic blood pressure (mmHg) 169.35 ± 20.90 160.43 ± 17.18 114.78 ± 5.11 
Diastolic blood pressure (mmHg) 103.61 ± 12.32 100 ± 9.53 73.48 ± 4.87 
BMI before pregnancy (kg/m
2
) 28.52 ± 5.06 28.76 ± 6.04 25.08 ± 1.69 
BMI during pregnancy (kg/ m
2
) 32.18 ± 4.84 35.10 ± 6.56 31.02 ± 1.96 
Birth weight (gr) 1363.48 ± 486.58 2945.00 ± 675.76 2730.43 ± 186.92 
 
Based on the table, it is known that early-
onset and late-onset preeclampsia have respondents 
with almost the same age, namely 32 years, whereas 
in normal pregnancies the average age is 29 years. In 
the early onset preeclampsia group, the systolic blood 
pressure is higher than the late-onset preeclampsia 
and normal pregnancy (169.35 ± 20.90 mmHg vs 
160.43 ± 17.18 mmHg vs 114.78 ± 5.11 mmHg). 
Likewise, with diastole blood pressure found in the 
preeclampsia group, early onset is higher than late-
onset preeclampsia and normal pregnancy (103.61 ± 
12.32 mmHg vs 100 ± 9.53 mmHg vs 73.48 ± 4.87 
mmHg). In the late-onset preeclampsia group, the 
mean IMT before pregnancy was higher than that of 
early-onset and normal pregnancy (28.76 ± 6.04 
kg/m
2
 vs 28.52 ± 5.06 kg/m
2
 vs 25.08 ± 1.69 kg/m
2
). 
Similar results were found in IMT during pregnancy 
(35.10 ± 6.56 kg/m
2
 vs 32.18 ± 4.84 kg/m
2
 vs 31.02 ± 
1.96 kg/m
2
). 
Table 2: HIF-1α levels and the onset of preeclampsia  
Variable Preeclampsia Onset P-value 
 EOPE (n = 23) LOPE (n = 23) Normal (n = 23)  
HIF-1α (pg/ml) 1366.96 ± 733.40 916.87 ± 466.06 716.77 ± 541.08 0.003 
 
As described in Table 2, there was the 
difference in maternal serum HIF-1α between groups 
early-onset preeclampsia, late-onset preeclampsia, 
and normal pregnancy, in which the mean level of 
maternal HIF-1α was 1366.96 ± 733.40 pg/ml, 916.87 
± 466.06 pg/ml and 716.77 ± 541.08 pg/ml. The mean 
of maternal HIF-1α level was statistically different 
between early-onset preeclampsia, late-onset 
preeclampsia and normal pregnancy (p-value < 0.05). 
There is a significant difference between the levels of 
HIF-1α and the onset of preeclampsia, as shown in 
Figure 1. 
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Figure 1: Boxplot Levels of HIF-1α with the Onset of Preeclampsia 
 
From Figure 1, it is known that HIF-1α levels 
are higher in early-onset preeclampsia than late-onset 
preeclampsia and normal pregnancy.  
 
 
Discussion 
 
Although the aetiology of preeclampsia is 
unclear, abnormalities in the placenta are undoubtedly 
the pathogenesis of preeclampsia [1], [8]. 
Accumulation of hypoxia-inducible factor 1 α (HIF-1α 
is commonly an acute and beneficial respond to 
hypoxia, while chronically elevated HIF-1α is 
associated with multiple disease conditions, including 
preeclampsia [10]. 
The results of this study showed that the 
mean HIF-1α levels were significantly higher in both 
preeclampsia groups (early-onset and late-onset) 
compared to the normal pregnancy. Statistically, there 
is a significant difference with a value of p 0.003 (p < 
0.05) between levels of HIF-1α and the onset of 
preeclampsia. Whereas research conducted by Rath 
et al., (2014) obtained ROC curve analysis, HIF-1α 
nucleus expression was significant in the 
preeclampsia group compared to the control group (P 
= 0.0001) with 88.9% specificity and 88.9% sensitivity, 
whereas ELISA obtained HIF-1α serum levels higher 
(mean = 6,581 pg/ml) in the preeclampsia group than 
in the control group (mean = 4,947 pg/ml) [13]. Kimura 
et al., (2012) measuring the proportion of positive 
nuclei of HIF-1α in placental trophoblast cells and 
found that staining of HIF-1α was significantly higher 
in both groups of preeclampsia than in the control 
group. However, the more staining was observed in 
women with early-onset preeclampsia compared to 
women with late-onset preeclampsia [20]. HIF-1α is a 
major transducer of hypoxic signals in several tissues, 
including the human placenta. HIF-1α is very highly 
expressed in low oxygen environments in early 
pregnancy and plays an important role in the 
development and function of the placenta. HIF-1α also 
shows overexpression in the placenta of preeclamptic 
women, together with soluble Fms-like tyrosine 
kinase-1 (sFlt-1) and soluble endoglin (SEng) [21]. 
HIF-1 was transcripted by much dependent oxygen 
genes that code protein, which correlates to 
angiogenesis and cell metabolism [13]. HIF-1α plays a 
role in maintaining homeostatic state, inducing gene 
transcription such as VEGF and erythropoietin. When 
the level of oxygen is low, HIF-1α would express 
much more and helps placenta development on early 
pregnancies. Chaiworapongsa et al., (2014), 
considerable evidence supports a role for hypoxia in 
creating an environment that predisposes to 
implantation disorders, including preeclampsia: 
expression of HIF-1α and HIF-2α protein is increased 
in the placentas of women with pre-eclampsia [9]. 
During low oxygen conditions, HIF-1α is expressed 
high and helps placental development early in 
pregnancy. Excessive expression of HIF-1α has been 
observed in many inflammatory disorders, including 
cancer and preeclampsia [13]. This theory matches 
Rajakumar et al., (2003) that preeclampsia placenta 
got more over the expression of HIF-1α and HIF-2α 
compared to the normal placenta. Even explant villus 
oxygenation from preeclampsia placenta failed to 
lower HIF-1α and HIF-2α levels in vitro [15]. 
In this study it was found that HIF-1α levels 
were higher in EOPE than others, similar to the theory 
that the key mediator of this hypoxic condition is HIF-
1α. HIF-1α is included in the description by many 
dependent oxygen genes that encode proteins that 
are associated with angiogenesis and cell metabolism 
[13], [22]. Likewise, with research conducted by Roflo 
et al., (2010), it was found that oxygen disorders occur 
in placenta EOPE, but not in placental LOPE [21]. 
Hypoxic conditions affect HIF-1α levels. HIF-1α is the 
main mediator, which is the cellular response to 
oxygen pressure under pathological and physiological 
conditions. Other researchers also proved that HIF-1α 
levels in preeclampsia women were higher than 
controls [18]. However, it is different from the study by 
Davutoglu et al., (2017) which found no significant 
difference between HIF-1α levels in preeclampsia and 
control, and found that HIF-1α levels were greater in 
LOPE. They suspect that the mechanism of 
inflammation and independent oxygen is the dominant 
form of increasing HIF-1α in late-onset preeclampsia 
[22]. 
In the condition of early-onset preeclampsia 
that last a long time, uterine artery blood flow is 
damaged, and the reduction in placental blood flow 
and the severity of hypoxic changes and DNA 
oxidation damage is greater in the placenta, causing 
fetal growth restriction (FGR), therefore most women 
preeclampsia with FGR experiencing preeclampsia 
early-onset and inadequate trophoblast cell invasion 
and remodelling of incomplete spiral arteries often 
occur in early-onset preeclampsia women [20]. 
There are a significant difference level of HIF-
1α between in early-onset preeclampsia, late-onset 
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preeclampsia and normal pregnancy. Early-onset 
preeclampsia is the highest levels of serum HIF-1α. 
 
 
References 
 
1. Rigo J, Szendei G, Rosta K, et al. Leptin receptor gene 
polymorphisms in severe preeclampsia women. Gynecological 
Endocrinology. 2006; 22(9):521-525. 
https://doi.org/10.1080/01674820600915502 PMid:17071538 
2. Salimi S, Mashhadi FF, Naghavi A, et al. Different profile of 
serum leptin between early onset and late onset preeclampsia. 
Hindawi Publishing Corporation Disease Markers. 2014; 2014:1-7. 
https://doi.org/10.1155/2014/628476 PMid:24591763 
PMCid:PMC3925616 
 
3. Cunningham FG, et al. Hypetensive disorder in pregnancy. 
Dalam William Obstetric 23 ed. New York: McGraw-Hill Companies 
Inc., 2014. 
 
4. MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality 
from preeclampsia and eclampsia. ObstetGynecol. 2001; 
97(4):533-538. https://doi.org/10.1097/00006250-200104000-
00011 PMid:11275024 
 
5. Von Dadelszen P, Magee LA, Roberts JM. Subclassification of 
preeclampsia. Hypertens pregnancy. 2003; 22(2):143-148. 
https://doi.org/10.1081/PRG-120021060 PMid:12908998 
 
6. Ogge G, Chaiworapongsa T, Romero R, et al. Placental lesions 
associated with maternal underperfusion are more frequent in early 
onset than late onset preeclampsia. Journal of Perinatal Medicine. 
2011; 3(6):641-652. https://doi.org/10.1515/jpm.2011.098 
PMid:21848483 PMCid:PMC3213694 
 
7. Van der Merwe JL, Hall DR, Wright C, Schubert P, Grove D. Are 
early and late preeclampsia distinct subclasses of the disease-what 
does the placenta reveal?. Hypertension in pregnancy. 2010; 
29:457-467. https://doi.org/10.3109/10641950903572282 
PMid:20701467 
 
8. Roberts J. Pregnancy related hypertension. In (Creasy R, 
Resnik R, Iams JD, editors) maternal-fetal medicine: principles and 
practice 6. Philadelphia: Saunders Elsevier, 2009:650-88. 
https://doi.org/10.1016/B978-1-4160-4224-2.50038-7 
PMid:19486768 
 
9. Chaiworapongsa T, Chaemsaithong P, Yeo L, Romero R. Pre-
eclampsia part 1: current understanding of its pathophysiology. 
Nature Reviews Nephrology. 2014; 10(8):466. 
https://doi.org/10.1038/nrneph.2014.102 PMid:25003615 
PMCid:PMC5893150 
 
10. Iriyama T, Wang W, Parchim NF, et al. Hypoxia -independent 
up regulation of placental HIF-1 α gene expression contributes to 
the pathogenesis of preeclampsia. Hypertension. 2015; 
65(6):1307-1315. 
https://doi.org/10.1161/HYPERTENSIONAHA.115.05314 
PMid:25847948 PMCid:PMC4859813 
 
11. Adelman DM, Gertsenstein M, Nagy A, Simon MC, Maltepe E. 
Placental cell fates are regulated in vivo by HIF-mediated hypoxia 
responses. Genes & development. 2000; 14(24):3191-203. 
https://doi.org/10.1101/gad.853700 PMid:11124810 
 
12. Semenza GL, Agani F, Booth G, Forsythe J, Iyer N, Jiang BH, 
Leung S, Roe R, Wiener C, Yu A. Structural and functional analysis 
of hypoxia-inducible factor 1. Kidney international. 1997; 51(2):553-
5. https://doi.org/10.1038/ki.1997.77 PMid:9027737 
 
13. Rath G, Aggarwal R, Jawanjal P, Tripathi R, Batra A. HIF‐1 
Alpha and Placental Growth Factor in Pregnancies Complicated 
With Preeclampsia: A Qualitative and Quantitative Analysis. 
Journal of clinical laboratory analysis. 2016; 30(1):75-83. 
https://doi.org/10.1002/jcla.21819 PMid:25545166 
 
14. Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental 
development during the first trimester: implications for the 
pathophysiology of pre-eclampsia. Placenta. 2000; 21:S25-30. 
https://doi.org/10.1053/plac.1999.0522 
 
15. Rajakumar A, Conrad KP. Expression, ontogeny, and 
regulation of hypoxia-inducible transcription factors in the human 
placenta. Biology of reproduction. 2000; 63(2):559-69. 
https://doi.org/10.1095/biolreprod63.2.559 PMid:10906065 
 
16. Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha 
in preeclampsia pathogenesis. Biology of reproduction. 2012; 
87(6):1-8. https://doi.org/10.1095/biolreprod.112.102723 
PMid:23034156 
 
17. Bobek G, Surmon L, Mirabito KM, Makris A, Hennessy A. 
Placental Regulation of Inflammation and Hypoxia after TNF‐α 
Infusion in Mice. American Journal of Reproductive Immunology. 
2015; 74(5):407-18. https://doi.org/10.1111/aji.12417 
PMid:26220019 
 
18. Akhilesh M, Mahalingam V, Nalliah S, Ali RM, Ganesalingam 
M, Haleagrahara N. Hypoxia-inducible factor-1α as a predictive 
marker in pre-eclampsia. Biomedical reports. 2013; 1(2):257-8. 
https://doi.org/10.3892/br.2012.44 PMid:24648931 
PMCid:PMC3956219 
 
19. Akhilesh M, Mahalingam V, Nalliah S, Ali RM, Ganesalingam 
M, Haleagrahara N. Hypoxia-inducible factor-1α as a predictive 
marker in pre-eclampsia. Biomedical reports. 2013; 1(2):257-8. 
https://doi.org/10.3892/br.2012.44 PMid:24648931 
PMCid:PMC3956219 
 
20. Sastroasmoro S, Ismael S. Dasar-dasar metodologi penelitian 
klinis. Jakarta: Sagung Seto. 2011; 372.  
21. Kimura C, Watanabe K, Iwasaki A, Mori T, Matsushita H, 
Shinohara K, Wakatsuki A. The severity of hypoxic changes and 
oxidative DNA damage in the placenta of early-onset preeclamptic 
women and fetal growth restriction. The Journal of Maternal-Fetal 
& Neonatal Medicine. 2013; 26(5):491-6. 
https://doi.org/10.3109/14767058.2012.733766 PMid:23035823 
 
22. Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, Wang 
J, Post M, Caniggia I. Abnormalities in oxygen sensing define early 
and late onset preeclampsia as distinct pathologies. PloS one. 
2010; 5(10):e13288. https://doi.org/10.1371/journal.pone.0013288 
PMid:20967267 PMCid:PMC2953500 
 
23. Davutoglu A, AkkayaFirat A, Ozel A, et al. Evaluation of 
maternal serum hypoxia inducible factor-1α, progranulin and 
syndecan-1 levels in pregnancies with early- and late-onset 
preeclampsia. J Matern Fetal Neonatal Med. 2018; 31(15):1976-
1982. https://doi.org/10.1080/14767058.2017.1333098 
PMid:28574293 
 
 
